EXCLUSIVE-Warburg and Advent in the lead to acquire Baxter’s biopharma unit-sources

A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday.

admin